Last reviewed · How we verify

NCT03937700

Robot Based Gait Training Therapy for Pediatric Population With Cerebral Palsy Using the CPWalker

Active, enrolled NA Last updated 18 April 2025
What this trial tests

NA trial testing CPWalker Robotic Exoskeleton in Cerebral Palsy in 30 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
1 July 2019
Primary endpoint
1 December 2025
1 December 2025

Quick facts

Lead sponsorShirley Ryan AbilityLab
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment30
Start date1 July 2019
Primary completion1 December 2025
Estimated completion1 December 2025
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Shirley Ryan AbilityLab — full company profile →

Who can join

Adults 11 to 21, any sex, with Cerebral Palsy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This trial is being conducted to determine if the CPWalker can be used as a gait training intervention for pediatric patients with gait impairments due to cerebral palsy

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Cerebral Palsy

Currently open trials in the same condition.

Other Shirley Ryan AbilityLab trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03937700.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing